Publication: Stem cells and cancer immunotherapy: Arrowhead’s 2nd annual cancer immunotherapy conference
Loading...
Open/View Files
Date
2014
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Bot, A., M. Chiriva-Internati, A. Cornforth, B. J. Czerniecki, S. Ferrone, K. Geles, P. D. Greenberg, et al. 2014. “Stem cells and cancer immunotherapy: Arrowhead’s 2nd annual cancer immunotherapy conference.” Journal for Immunotherapy of Cancer 2 (1): 6. doi:10.1186/2051-1426-2-6. http://dx.doi.org/10.1186/2051-1426-2-6.
Abstract
Investigators from academia and industry gathered on April 4 and 5, 2013, in Washington DC at the Arrowhead’s 2nd Annual Cancer Immunotherapy Conference. Two complementary concepts were discussed: cancer “stem cells” as targets and therapeutic platforms based on stem cells.
Description
Other Available Sources
Research Data
Keywords
Immunotherapy, Cancer stem cells, Hematopoietic stem cells, Adoptive T cell therapy, Antibodies, Vaccines
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service